on August 27, 2026

How to Reduce Fatty Liver: What the Research Actually Shows for Adults Over 50

FATTY LIVER  |  MASLD  |  INDIA

By Meru Activs Editorial Team  |  Medically reviewed by Dr. Radhika Vishveshwar  |  MBBS, MD  |  Consultant Geriatric Physician

Indian couple in their 50s doing a morning walk in a park — lifestyle changes for fatty liver reduction

How to reduce fatty liver is one of the most common questions asked by Indian adults after a MASLD diagnosis. The answer is encouraging: fatty liver in its early and moderate stages can improve significantly with the right approach. A 2025 review in the New England Journal of Medicine describes MASLD as the most common chronic liver disease worldwide. A 2026 Lancet study found approximately 39% of Indian adults screened have it. Yet the same research confirms that lifestyle change remains the most effective intervention at early stages. If you are not yet sure whether you have it, our guide to the symptoms of fatty liver is a good place to start.

39%

of Indian adults screened have MASLD
Lancet Regional Health, 2026

#1

MASLD is the most common chronic liver disease worldwide
NEJM, 2025

Can a Fatty Liver Go Back to Normal?

Yes. Grade 1 and Grade 2 MASLD can improve meaningfully with sustained dietary and lifestyle changes. Unlike many chronic liver conditions, the accumulation of fat in liver cells is not permanent in the early stages. What "going back to normal" means clinically:

01

Liver Enzyme Normalisation

SGPT (ALT) and SGOT (AST) levels that were mildly elevated can return to within normal reference ranges.

02

Ultrasound Grade Improvement

A liver graded Grade 2 on ultrasound can revert to Grade 1 or normal echogenicity with sustained intervention.

03

Metabolic Marker Improvement

Fasting glucose, insulin resistance markers, and triglyceride levels typically improve in parallel with liver fat reduction.

!

The Important Caveat

The more advanced the disease, the harder improvement becomes. Grade 3 steatosis, MASH, and fibrosis are significantly harder to reverse: the strongest argument for acting early.

What Is the Current Treatment for Fatty Liver in India?

As of 2025, there is no drug approved specifically for early-stage MASLD (Grades 1 and 2) in India. Across all major international guidelines (AASLD, EASL, and the Indian National Liver Association), the first-line treatment is:

  1. Dietary modification, focused on reducing refined carbohydrates, added sugars, and total caloric load.
  2. Body Fat Reduction, specifically targeting visceral fat through a sustainable caloric deficit.
  3. Physical activity, including both aerobic exercise (walking, swimming) and resistance training.
  4. Comorbidity management, specifically controlling blood glucose, blood pressure, and dyslipidemia if present.
On supplements:

Nutritional supplements are not a replacement for these steps. They are studied as adjuncts alongside lifestyle changes, not as standalone treatments. The research on essential phospholipids, Vitamin E, and silymarin is covered in the supplements section below.

How to Reduce Fatty Liver Through Diet

Diet is the primary lever. Multiple clinical studies confirm that targeted dietary changes reduce liver fat more effectively than any currently available medication at the early-stage level. Two approaches have the strongest evidence. For a fuller breakdown, including breakfast options and drinks, see our complete guide to what to eat with fatty liver.

Reduce Refined Carbohydrates and Added Sugars

Excess dietary carbohydrates, particularly refined grains and sugars, drive de novo lipogenesis, the process by which the liver converts excess carbohydrates into fat. This is the central mechanism of MASLD in individuals without heavy alcohol consumption. For Indian adults over 50, the most impactful changes:

Foods to Reduce or Avoid Better Alternative
White rice (large portions) Smaller serving (one-third of previous) or millets Reduce
Maida-based foods (white bread, biscuits, puri, paratha with maida) Whole wheat roti, jowar, bajra Reduce
Fruit juices, packaged drinks, sweetened chai Plain water, unsweetened green tea, plain chaas Avoid
Packaged snacks (namkeen, biscuits) Roasted chana, a small handful of nuts, fresh fruit Reduce
Alcohol (even small quantities) No safe level in MASLD Avoid

Increase Choline Intake

Choline is the nutrient most directly linked to the liver's ability to export fat. Without adequate phosphatidylcholine (which requires dietary choline for synthesis), fat becomes trapped in liver cells rather than being transported out.

The research on choline and fatty liver:

A landmark study by Fischer and colleagues (American Journal of Clinical Nutrition, 2007) found that 80% of post-menopausal women and men placed on a low-choline diet developed hepatic steatosis. Most Indian adults consume significantly less choline than the internationally recognised adequate intake level.

Food Choline Content
Eggs One of the richest sources available in India Include
River fish (rohu, catla, coastal varieties) High choline, also provides Omega-3 Include
Rajma, chana dal, moong dal Smaller quantities of choline, plus fibre Include
Organ meat (liver) Highest choline concentration of any food Consider

Increase Anti-Inflammatory Foods

A consistent body of research links chronic inflammation with MASLD progression. Anti-inflammatory foods to prioritise:

Food Why It Helps
Turmeric Curcumin studied for anti-inflammatory and hepatoprotective properties Include
Walnuts and flaxseeds Plant-based sources of Omega-3 fatty acids Include
Spinach, methi, palak Antioxidants that support liver function Include
Berries and citrus fruits Polyphenols that reduce hepatic oxidative stress Include
Cold-pressed oils (in moderation) Replace refined seed oils for cooking Prefer

How Long Does It Actually Take to Reduce Fatty Liver?

The 14-day claim: an honest assessment

Many online articles claim fatty liver can be reduced in 14 days. This is not supported by published clinical research. The liver responds to sustained metabolic change over weeks and months, not days. Setting realistic expectations is essential to maintaining changes long enough to produce meaningful results.

What the clinical evidence actually shows, by timeframe:

Timeframe What May Change Marker to Track
Week 1–2 Dietary habits begin changing. Blood glucose variability may reduce. No measurable change in liver steatosis grade. None expected at this stage
Week 4–6 SGPT (ALT) levels may begin to move downward if dietary changes are consistent. Liver inflammation markers may reduce early. Repeat LFT (blood test) if baseline was elevated
Week 8–12 Early metabolic improvement. Body fat reduction of 3–5% may begin to affect liver fat measurably. Some enzyme normalisation. LFT repeat, weight check, glucose markers
Week 12–24 Ultrasound-visible change in liver steatosis grade becomes possible with sustained 5–10% body fat reduction and consistent dietary adherence. Repeat ultrasound (if baseline was Grade 2 or above)
6–12 Months Most studies showing significant liver fat reduction are designed at this duration. SGPT normalisation and ultrasound grade improvement are the primary endpoints. Full LFT panel, repeat ultrasound, lipid profile
The key variable is consistency, not speed.

Crash dieting or extreme caloric restriction can temporarily worsen MASLD: the liver receives a flood of mobilised fat from adipose tissue that it cannot process efficiently, paradoxically increasing steatosis. Sustainable, moderate change over months produces the most durable improvement.

The Role of Weight Loss in Fatty Liver Reduction

Body fat reduction is the most consistently evidence-supported intervention for MASLD across all major international guidelines. The relationship between body fat loss and liver fat reduction is dose-dependent:

3–5%

Measurable reduction in liver steatosis on imaging

7–10%

Reduction in liver inflammation and early fibrosis improvement in more advanced disease

10%+

Associated with significant histological improvement across multiple clinical outcomes

A practical example:

For a person weighing 75 kg, a 5% reduction means losing 3.75 kg, achievable over 8 to 12 weeks at a safe rate of 0.5 kg per week through dietary changes and regular walking.

Important Considerations for Adults Over 50

  • Preserve muscle mass. Muscle naturally declines after 50 (sarcopenia). Weight loss strategies should include adequate protein intake and resistance exercise alongside caloric reduction.
  • Avoid very low calorie diets. Diets below 800 calories per day are not recommended without medical supervision, as they can accelerate muscle loss and may paradoxically worsen liver fat short-term.
  • Walk regularly. 30 to 45 minutes per day reduces liver fat independently of weight loss through its effect on insulin sensitivity and hepatic lipid oxidation.

What the Research Shows on Supplements for MASLD

Supplements studied in the context of MASLD work as adjuncts to dietary and lifestyle change. They do not replace the foundational modifications described above.

Is Ayurvedic Medicine Effective for Fatty Liver?

Several herbs used in Indian traditional medicine have been studied for liver health. The evidence varies significantly by herb and delivery form. Silymarin (milk thistle) has one of the strongest evidence bases of any botanical compound studied in MASLD, having been evaluated in Cochrane-level systematic reviews. The critical distinction is in the delivery form:

Standard vs. Liposomal Silymarin:

Standard silymarin tablets have poor water solubility and limited gastrointestinal absorption. A silymarin-phospholipid complex (liposomal form) delivers significantly higher bioavailability. A 2025 prospective clinical study (Gheonea et al., International Journal of Molecular Sciences) found that a combination of silymarin, Vitamin E, and essential phospholipids significantly improved liver steatosis grade, fibrosis, and metabolic parameters over 6 months.

Three nutrients with the strongest published evidence in MASLD:

🧬

Essential Phospholipids

Address the core cellular mechanism of MASLD: fat trapped in liver cells due to phosphatidylcholine deficiency. EPL integrates into liver cell membranes, restores membrane fluidity, and supports VLDL assembly, the process by which the liver exports fat. Supported by a Cochrane systematic review (2019) and a 2025 prospective clinical trial.

🌿

Silymarin (Milk Thistle)

The active compound from milk thistle, evaluated in Cochrane-reviewed systematic analyses. Standard tablets have low bioavailability. A liposomal or phospholipid-complexed form significantly improves absorption and hepatoprotective effect.

☀️

Vitamin E

A systematic review (Usman et al., 2018) found that Vitamin E may support normal liver enzyme levels (ALT and AST) and help reduce markers of liver inflammation in MASLD patients.

Phospholipid-Based Liver Support

Meru Activs™ Fatty Liver Support uses Essential Phospholipids in a phospholipid delivery system, the same form studied in peer-reviewed clinical research for MASLD. Designed specifically for Indian adults over 50.

Learn More About Fatty Liver Support

When to See Your Doctor and What to Ask

If you have a fatty liver diagnosis or suspect you may have MASLD, the first step is a conversation with your doctor. See your doctor urgently if you experience:

  • Jaundice (yellowing of skin or eyes)
  • Significant abdominal swelling or pain in the upper right abdomen
  • Rapid unexplained weight loss with fatigue
  • Confusion or disorientation (may signal advanced liver dysfunction)

Questions to Raise at Your Next Appointment

  • "My SGPT was elevated. Can we repeat the blood test after 8 to 12 weeks to see if the dietary changes I have made are having an effect?"
  • "What is a safe and realistic weight loss target for me given my current weight and health conditions?"
  • "Is a repeat abdominal ultrasound appropriate at 6 months given my current grade?"
  • "Are there any nutritional supplements, such as essential phospholipids or Vitamin E, that would be appropriate alongside my dietary changes?"
  • "Given that I have diabetes as well, what specific dietary modifications are most important for both conditions simultaneously?"

Frequently Asked Questions

Can a fatty liver go back to normal?
Yes. Grade 1 and Grade 2 fatty liver (MASLD) can improve significantly with sustained dietary changes and lifestyle modification. Research confirms that liver enzyme levels can normalise and ultrasound-visible steatosis grade can improve with consistent intervention over 12 to 24 weeks. The degree of improvement depends on how consistently dietary changes are maintained, whether weight loss targets are met, and whether comorbidities such as diabetes are well managed.
How long does it take to reduce fatty liver?
Initial changes in liver enzyme levels (SGPT, SGOT) may be detectable within 4 to 6 weeks of consistent dietary and lifestyle change. Ultrasound-visible improvement in liver steatosis grade typically requires 12 to 24 weeks of sustained intervention. Most published clinical studies on fatty liver reduction are designed for 6 to 12 months, reflecting the time needed for significant and durable hepatic fat reduction.
Is it possible to reduce fatty liver in 14 days?
Significant reduction in fatty liver in 14 days is not supported by published clinical research. Within 14 days of consistent dietary changes, blood glucose regulation may improve and initial inflammation reduction may begin. However, measurable change in liver steatosis grade on ultrasound, which is the clinically relevant marker, requires 12 to 24 weeks of consistent effort. The 14-day framing risks discouragement when results are not visible within that window.
What is the fastest way to reduce fatty liver?
The approach with the strongest and fastest evidence is a combination of targeted dietary change (reducing refined carbohydrates and added sugars), a moderate and sustainable caloric deficit to promote 0.5 kg per week of weight loss, and regular physical activity including both walking and resistance exercise. These three changes together produce liver fat reduction more reliably than any single intervention. There is no clinically validated shortcut that bypasses this combination.
Can fatty liver be reversed without medication?
Yes. International guidelines from AASLD, EASL, and the Indian National Liver Association consistently list lifestyle modification as the first-line intervention for Grade 1 and Grade 2 MASLD. As of 2025, no drug is approved in India specifically for early-stage MASLD. Lifestyle-based reversal is well-documented in the clinical literature, with multiple studies showing enzyme normalisation and ultrasound grade improvement through dietary and weight management alone.
What exercise is good for fatty liver?
Both aerobic exercise and resistance training independently reduce liver fat in MASLD, including in individuals who do not lose weight. For adults over 50, a practical starting point is 30 to 45 minutes of brisk walking, 5 days per week. Adding resistance training (bodyweight exercises, light dumbbells) 2 to 3 days per week helps preserve muscle mass and improves insulin sensitivity, both of which directly support liver fat reduction. Consistency matters more than the specific type of exercise.
Does Liv 52 cure fatty liver?
Liv 52 has hepatoprotective evidence in alcohol-related liver conditions and drug-induced liver injury. However, its clinical evidence base for MASLD specifically is limited in terms of study scale and design compared to the evidence for silymarin-phospholipid complexes, which have been evaluated in Cochrane-reviewed systematic analyses and prospective clinical trials using MASLD-specific endpoints. Whether either is appropriate for your specific situation is a decision best made with your doctor.
What is the danger zone for fatty liver?
MASH (Metabolic dysfunction-Associated Steatohepatitis) is the danger zone: this is when inflammation accompanies fat accumulation, increasing the risk of fibrosis (scarring) and cirrhosis if left unaddressed. Fibrosis is graded F0 to F4, and F4 (cirrhosis) is associated with significantly increased risk of liver failure and hepatocellular carcinoma. Regular monitoring through blood tests and imaging, guided by your doctor, is the most reliable way to know where you stand.
Can I live a long life with fatty liver?
Yes, with appropriate management. Grade 1 and Grade 2 MASLD does not significantly shorten life expectancy on its own when addressed through lifestyle changes. The main risk in MASLD patients is cardiovascular disease, not liver failure. This risk is primarily determined by the same metabolic factors (insulin resistance, dyslipidemia, hypertension) that also drive MASLD. Addressing these through diet, exercise, and appropriate medical management is the most effective way to protect both liver health and overall longevity.
How do I know if my fatty liver is getting better?
The most reliable way is through blood tests and periodic imaging. SGPT (ALT) and SGOT (AST) levels that were elevated should trend downward within 6 to 12 weeks of consistent dietary change. An abdominal ultrasound repeated at 6 to 12 months can confirm whether steatosis grade has changed. Subjective markers that often improve alongside liver fat reduction include reduced fatigue, improved energy after meals, reduced upper right abdomen heaviness, and gradual weight reduction. Your doctor can guide the appropriate monitoring interval based on your baseline severity.

References

  1. Rinella ME et al. New England Journal of Medicine, 2025. DOI: 10.1056/NEJMra2412865
  2. Reinson T et al. BMJ Medicine 2026;5(1):e002038. DOI: 10.1136/bmjmed-2025-002038
  3. Arvind M et al. The Lancet Regional Health Southeast Asia, 2026. DOI: 10.1016/j.lansea.2026.100723
  4. GBD 2023 MASLD Collaborators. The Lancet Gastroenterology and Hepatology, April 2026.
  5. Kalra S, Das AK et al. Journal of Association of Physicians of India 2022;70(8):11–12.
  6. Rinella ME et al. (AASLD, EASL, ALEH). Journal of Hepatology 2023;79(6):1542–1556.
  7. Fischer LM et al. American Journal of Clinical Nutrition 2007;85:1275–1285.
  8. Gheonea DI et al. International Journal of Molecular Sciences 2025;26(12):5427. DOI: 10.3390/ijms26125427
  9. Varganova et al. Cochrane Database of Systematic Reviews, 2019. PMC6447141
  10. Petcu & Popovic. EFSM Online, 2022.
  11. Dajani & Popovic. World Journal of Clinical Cases 2020;8(21):5235–5249.
  12. Padma L et al. Indian Journal of Clinical Practice 2013; Vol. 23, No. 11.
  13. Stefan N et al. Phase IV RCT protocol (EudraCT: 2021-006069-39). PMC, 2024.
  14. Usman M et al. Systematic review on Vitamin E in MASLD, 2018.
A note on terminology: This article uses MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease), the current globally accepted term following the 2023 multi-society Delphi consensus (AASLD, EASL, ALEH), adopted by WHO in ICD-11 from January 2024. If your doctor has previously used fatty liver, NAFLD, or MAFLD, they are referring to the same condition.
Disclaimer: This article is for general information and educational purposes only and does not constitute medical advice. If you are experiencing symptoms of concern, please consult a qualified healthcare professional. Nutraceutical supplements are not intended to diagnose, treat, cure, or prevent any disease. Always consult your doctor before starting any supplement, particularly if you are managing a health condition or are on medication. Meru Activs™ Fatty Liver Support contains soy-derived essential phospholipids. Individuals with soy sensitivity should consult their doctor before use.
Dr. Radhika Vishveshwar
MEDICAL REVIEWER

Dr. Radhika Vishveshwar

MBBS, MD | Consultant Geriatric Physician | Medical Reviewer, Meru Activs

Dr. Radhika Vishveshwar is a Consultant Geriatric Physician with a clinical focus on healthy ageing, metabolic health, and preventive care for adults over 50. She is the medical reviewer for meruactivs.com, ensuring that all health and nutrition content published on the website is grounded in clinical evidence and safe for older adults. Dr. Radhika holds an MBBS and MD and brings a practice-based perspective to every review, combining published research with the real-world health concerns she sees in her geriatric patients every day. View Full Profile →